Page last updated: 2024-11-01

nitroglycerin and Experimental Hepatoma

nitroglycerin has been researched along with Experimental Hepatoma in 2 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Research Excerpts

ExcerptRelevanceReference
"Nitroglycerin was active to enhance transduction of large tumors with trabecular or pseudoglandular histological pattern, which were impermeable to adenoviral vectors even after histamine or angiotensin treatments."1.31A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds. ( Alzuguren, P; Bilbao, R; Bustos, M; Drozdzik, M; Pajares, MJ; Prieto, J; Qian, C, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamano, S1
Ward, JM1
Diwan, BA1
Keefer, LK1
Weghorst, CM1
Calvert, RJ1
Henneman, JR1
Ramljak, D1
Rice, JM1
Bilbao, R1
Bustos, M1
Alzuguren, P1
Pajares, MJ1
Drozdzik, M1
Qian, C1
Prieto, J1

Other Studies

2 other studies available for nitroglycerin and Experimental Hepatoma

ArticleYear
Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats.
    Carcinogenesis, 1996, Volume: 17, Issue:11

    Topics: Animals; Base Sequence; Genes, p53; Genes, ras; Glutathione Transferase; Hepatectomy; Immunohistoche

1996
A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.
    Gene therapy, 2000, Volume: 7, Issue:21

    Topics: Actins; Adenoviridae; Angiotensin II; Animals; Diethylnitrosamine; Extracellular Matrix; Fibronectin

2000